Galectin Therapeutics Inc.
Status: Publicly traded
Direct answer
Galectin Therapeutics Inc. is publicly traded on NASDAQ under the ticker GALT.
Galectin Therapeutics Inc. is a biopharmaceutical company in the clinical development phase, dedicated to discovering and advancing new therapies for a spectrum of illnesses, including fibrotic disorders and various cancers. The company's flagship therapeutic agent is belapectin (GR-MD-02), an inhibitor of galectin-3, which is a complex polysaccharide polymer. This compound is currently undergoing Phase III clinical...
Can you invest in Galectin Therapeutics Inc.?
Yes. Galectin Therapeutics Inc. is publicly traded on NASDAQ under the ticker GALT.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Galectin Therapeutics Inc.
Detailed equity research is provided by MarketSnap.